Fraudulent IPO Funding Leads to Restrictions on Company & Promoters

The case involved fraudulent funding of IPO applications to meet listing requirements and misappropriation of IPO proceeds. The company and connected entities were found to have funded IPO applicants and diverted IPO proceeds to reimburse the funding entities. The company failed to provide adequate documentation for fund utilization. As a result, the court directed the promoters to make a public offer, restrained the company from accessing the securities market for 8 years, and imposed restrictions on holding directorial positions and trading securities. The company faced compulsory delisting if public shareholding decreased.

---

---

Issues Involved:
1. Connection among Noticees and funding of IPO.
2. Utilization of IPO proceeds as per the stated objects in the Prospectus.

Issue I: Connection and Funding of IPO

The case involves allegations that the company and other Noticees deployed a scheme in the IPO of HPC Biosciences Ltd. to fraudulently achieve the threshold of minimum applications required for listing. The investigation revealed that certain entities connected with the company funded IPO applicants, and the IPO proceeds were subsequently transferred to these funding entities. The Noticees were interconnected through fund movements, common directorships, and shared addresses.

The company issued 45,00,000 equity shares in the IPO, and out of the total shares allotted, 13,24,000 shares were funded by the connected entities, representing 29.03% of the total shares allotted. The investigation found that the company transferred approximately INR 15.65 Crore out of the INR 15.96 Crore raised in the IPO to various entities, including INR 10.59 Crore to the funding entities.

The company and its directors provided evasive replies and failed to furnish supporting documents to justify the fund transfers. The underwriting agreement cited by the company did not impose an obligation on the underwriter to subscribe to the entire unsubscribed portion of the IPO, and the company's conduct contradicted its defense.

The company and its connected entities were found to have fraudulently funded the IPO applications to achieve the mandatory subscription threshold of 90%. The scheme involved the company and its connected entities funding the IPO applicants and subsequently reimbursing the funding entities from the IPO proceeds.

Issue II: Utilization of IPO Proceeds

The company raised INR 15.96 Crore through the IPO, but failed to provide supporting documents for the utilization of the IPO proceeds. The company claimed to have utilized INR 8.99 Crore for development of farm land, INR 27.03 Lakh for issue expenses, and INR 2.20 Lakh for miscellaneous expenses. However, the company did not provide details for the remaining INR 6.68 Crore.

The agreements provided by the company for land development were found to be unregistered, unenforceable, and lacking in credibility. The company failed to produce any verifiable documents to support its claims of fund utilization. The investigation revealed discrepancies and contradictions in the company's submissions, indicating that the funds were not utilized for the stated objects of the IPO.

The company transferred INR 15.65 Crore out of the IPO proceeds to various entities, including INR 10.59 Crore to the funding entities, without providing any legitimate explanation or supporting documents. The investigation concluded that the funds were diverted to reimburse the funding entities for their role in making the IPO successful.

Judgment and Directions:

1. Noticee nos. 2 and 3 (promoters of the Company) are directed to make a public offer to acquire shares of the Company from public shareholders and acquire the shares offered in response to the public offer within three months.
2. BSE is to facilitate valuation of shares and compulsorily delist the Company if the public shareholding reduces below the minimum level.
3. The Company is restrained from accessing the securities market for 8 years.
4. Noticee nos. 2 and 3 are restrained from holding any directorial or managerial position in any listed public company or public company intending to raise money from the public for 3 years.
5. The Noticees are prohibited from buying, selling, or dealing in the securities market for the specified periods.

The order shall come into force immediately, and a copy of the order is to be forwarded to the Noticees, all recognized stock exchanges, depositories, and registrar and transfer agents for ensuring compliance.

---